论文部分内容阅读
目的分析影响高血压脑出血短期预后的相关因素。方法选择2013年10月—2014年10月收治的80例高血压脑出血患者作为研究对象,所有患者均于发病6 h内入院,动态监测患者血压变化情况。统计患者收缩压、舒张压、出血部位、出血量、性别、年龄等资料,根据患者神经功能缺损评分得分情况分为好转组22例与未好转组58例,分析影响高血压脑出血患者短期预后的相关因素。计数资料采用χ2检验,计量资料采用t检验,采用多因素Logistic回归分析高血压脑出血短期预后的影响因素,P<0.05为差异有统计学意义。结果年龄(OR=5.647,95%CI为2.621~12.166)、格拉斯哥昏迷指数(Glasgow coma scale,GCS)得分(OR=0.322,95%CI为0.101~0.796)是影响高血压脑出血患者短期预后的独立影响因素。结论高龄、GCS得分低是导致高血压脑出血患者短期预后不良的独立危险因素。为改善患者预后,必须重视对高龄、意识状态较差脑出血患者的治疗与评估,确立有效的诊疗方案,以优化其生存质量。
Objective To analyze the related factors that affect the short-term prognosis of hypertensive intracerebral hemorrhage. Methods Eighty hypertensive intracerebral hemorrhage patients who were admitted to our hospital from October 2013 to October 2014 were selected as study subjects. All patients were admitted within 6 hours after onset of illness and their blood pressure was dynamically monitored. Statistics patients with systolic blood pressure, diastolic blood pressure, bleeding site, blood loss, gender, age and other information, according to patients with neurological deficit score was divided into improved group of 22 cases and 58 cases of non-improved group analysis of short-term prognosis of patients with hypertensive intracerebral hemorrhage Related factors. Counting data using χ2 test, measurement data using t test, using multivariate Logistic regression analysis of short-term prognosis factors of hypertensive intracerebral hemorrhage, P <0.05 for the difference was statistically significant. Results The Glasgow coma scale (GCS) score (OR = 0.322, 95% CI 0.101 to 0.796) was associated with short-term prognosis in patients with hypertensive intracerebral hemorrhage (OR = 5.647, 95% CI 2.621-12.126) Independent factors. Conclusions In elderly patients, low GCS score is an independent risk factor for short-term prognosis in patients with hypertensive intracerebral hemorrhage. In order to improve the prognosis of patients, we must attach importance to the elderly, poor consciousness of patients with cerebral hemorrhage treatment and evaluation, the establishment of effective treatment programs to optimize their quality of life.